We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

211 hedge funds and large institutions have $3.11B invested in Cytokinetics in 2021 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 97 increasing their positions, 45 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

193% more call options, than puts

Call options by funds: $16.7M | Put options by funds: $5.69M

116% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 45

115% more capital invested

Capital invested by funds: $1.45B → $3.11B (+$1.67B)

92% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 25

60% more funds holding in top 10

Funds holding in top 10: 5 → 8 (+3)

11% more funds holding

Funds holding: 190 → 211 (+21)

2.7% more ownership

Funds ownership: 105.38% → 108.08% (+2.7%)

Holders
211
Holders Change
+21
Holders Change %
+11.05%
% of All Funds
3.69%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.14%
New
48
Increased
97
Reduced
45
Closed
25
Calls
$16.7M
Puts
$5.69M
Net Calls
+$11M
Net Calls Change
+$6.59M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$118M
2
BlackRock
BlackRock
New York
+$47.4M
3
PHS
PFM Health Sciences
California
+$43.4M
4
Franklin Resources
Franklin Resources
California
+$29.4M
5
CAM
Cormorant Asset Management
Massachusetts
+$29.4M

Top Sellers

Rank Fund Capital Flow
1
MWNA
Marshall Wace North America
New York
-$32.4M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$14.1M
3
VC
Vivo Capital
California
-$13.9M
4
LGM
Logos Global Management
California
-$11.8M
5
IHAM
Integral Health Asset Management
New York
-$11M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
76
ALPS Advisors
Colorado
$3.66M +$231K +7,862 +8%
MAP
77
Moody Aldrich Partners
Massachusetts
$3.58M +$2.95M +100,180 New
Squarepoint
78
Squarepoint
New York
$3.27M -$2.25M -76,333 -46%
State of Wisconsin Investment Board
79
State of Wisconsin Investment Board
Wisconsin
$3.19M -$144K -4,900 -5%
State of New Jersey Common Pension Fund D
80
State of New Jersey Common Pension Fund D
New Jersey
$3.14M -$471K -16,001 -15%
BNP Paribas Financial Markets
81
BNP Paribas Financial Markets
France
$3.11M +$1.57M +53,389 +159%
CS
82
Credit Suisse
Switzerland
$3.1M -$323K -10,984 -11%
Assenagon Asset Management
83
Assenagon Asset Management
Luxembourg
$3.04M -$3.34M -113,516 -57%
Prudential Financial
84
Prudential Financial
New Jersey
$3.02M +$354K +12,024 +16%
Barclays
85
Barclays
United Kingdom
$2.98M +$888K +30,153 +57%
Wells Fargo
86
Wells Fargo
California
$2.96M +$1.17M +39,699 +92%
SSA
87
Schonfeld Strategic Advisors
New York
$2.84M +$1.74M +59,216 +292%
Comerica Bank
88
Comerica Bank
Texas
$2.8M +$255K +8,645 +13%
ECM
89
ExodusPoint Capital Management
New York
$2.74M +$1.33M +45,070 +143%
SEI Investments
90
SEI Investments
Pennsylvania
$2.73M +$1.36M +46,054 +151%
ERSOT
91
Employees Retirement System of Texas
Texas
$2.69M – – –
JG
92
Jefferies Group
New York
$2.59M +$2.13M +72,500 New
KeyBank National Association
93
KeyBank National Association
Ohio
$2.53M +$2.23M +75,692 New
Canada Life
94
Canada Life
Manitoba, Canada
$2.53M +$298K +10,133 +17%
UBS AM
95
UBS AM
Illinois
$2.48M +$191K +6,475 +10%
IIM
96
Ironwood Investment Management
Massachusetts
$2.43M -$8.15K -277 -0.4%
Thrivent Financial for Lutherans
97
Thrivent Financial for Lutherans
Minnesota
$2.41M +$261K +8,858 +15%
SG Americas Securities
98
SG Americas Securities
New York
$2.39M +$1.48M +50,152 +299%
Ohio Public Employees Retirement System (OPERS)
99
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.38M – – –
COPPSERS
100
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$2.26M +$243K +8,268 +15%
2 3
4
5 6

CYTK Hedge Fund Activity: Q3 2021 in Review

211 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2021, worth a combined $3.11B — up 115% from $1.45B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new CYTK positions and 25 closed out — a net gain of 23 holders — while 97 added to existing stakes and 45 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $118M. The largest seller was Marshall Wace North America, cutting an estimated $32.4M.

  • 211 institutional investors held Cytokinetics (CYTK) as of Q3 2021, up from 190 in Q2 2021.
  • Funds reported $3.11B of Cytokinetics stock for Q3 2021, up 115% quarter-over-quarter.
  • 48 funds opened new Cytokinetics positions in Q3 2021 and 25 closed out, a net change of +23 holders.
  • The largest Cytokinetics buyer in Q3 2021 was Fidelity Investments, an estimated $118M added.
  • The largest Cytokinetics seller in Q3 2021 was Marshall Wace North America, an estimated $32.4M sold.

Based on aggregated 13F filings for Q3 2021.